U.S. Markets open in 7 hrs 49 mins

How Analysts View BioMarin Pharmaceutical in August

Daniel Collins
How Analysts View BioMarin Pharmaceutical in August

On August 30, BioMarin Pharmaceutical (BMRN) stock closed at $99.26, which is ~7% below its 52-week high of $106.20 on August 2. It hit its 52-week low of $75.81 on April 6.